Biomerica Inc (BMRA)vsGE HealthCare Technologies Inc. (GEHC)
BMRA
Biomerica Inc
$1.70
-1.73%
HEALTHCARE · Cap: $7.91M
GEHC
GE HealthCare Technologies Inc.
$80.66
+1.40%
HEALTHCARE · Cap: $34.25B
Smart Verdict
WallStSmart Research — data-driven comparison
GE HealthCare Technologies Inc. generates 490126% more annual revenue ($21.27B vs $4.34M). GEHC leads profitability with a 9.3% profit margin vs -115.5%. GEHC earns a higher WallStSmart Score of 65/100 (C+).
BMRA
Avoid23
out of 100
Grade: F
GEHC
Buy65
out of 100
Grade: C+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Attractively priced relative to earnings
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -125.8% — below average capital efficiency
Expensive relative to growth rate
Weak financial health signals
Negative free cash flow — burning cash
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : BMRA
The strongest argument for BMRA centers on Price/Book.
Bull Case : GEHC
The strongest argument for GEHC centers on P/E Ratio.
Bear Case : BMRA
The primary concerns for BMRA are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : GEHC
The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, Free Cash Flow.
Key Dynamics to Monitor
BMRA profiles as a turnaround stock while GEHC is a value play — different risk/reward profiles.
GEHC carries more volatility with a beta of 0.85 — expect wider price swings.
GEHC is growing revenue faster at 5.8% — sustainability is the question.
BMRA generates stronger free cash flow (-802,000), providing more financial flexibility.
Bottom Line
GEHC scores higher overall (65/100 vs 23/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Biomerica Inc
HEALTHCARE · MEDICAL DEVICES · USA
Biomerica Inc. (Ticker: BMRA) is an innovative biotechnology firm focused on developing and manufacturing cutting-edge diagnostic solutions catering to both medical and food industries. The company specializes in proprietary testing methods aimed at metabolic diseases, gastrointestinal disorders, and food intolerances, positioning itself to significantly enhance healthcare outcomes and diagnostic precision. With a commitment to addressing unmet medical needs, Biomerica capitalizes on strategic research partnerships and advanced technology integration, facilitating growth in the dynamic diagnostics market. Its patient-centric strategy further underscores the potential for transformative improvements in global healthcare diagnostics, making it a compelling prospect for institutional investors.
Visit Website →GE HealthCare Technologies Inc.
HEALTHCARE · MEDICAL DEVICES · USA
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?